Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Public Health. 2002 Mar;92(3):365-6.

Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies.

Author information

1
Center for Research in Women's Health, University of Alabama at Birmingham, Birmingham, AL, USA. stringer@uab.edu

Abstract

OBJECTIVES:

This study evaluated the validity of concerns about the toxicity of nevirapine (NVP) that have delayed its implementation as a perinatal HIV prevention strategy.

METHODS:

A decision analysis model compared 3 strategies: single-dose NVP, short-course zidovudine (ZDV), and no intervention.

RESULTS:

NVP would prevent more deaths than ZDV and no intervention as long as the rate of NVP toxicity did not exceed, respectively, 9 times that observed in the earlier NVP clinical trial and 42 times that observed in the clinical trial. NVP would be economically preferable to ZDV as long as the rate of toxicity did not exceed 22 times that observed in the clinical trial.

CONCLUSIONS:

Field implementation of NVP should not be delayed by concerns about its toxicity.

PMID:
11867311
PMCID:
PMC1447080
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center